Arbovirus Infections
16
4
6
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility
Therapeutics for Moderate and Severe Dengue
ARBOspot: Characterization of Arbovirus Specific T Cell Response in Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
"Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"
Cohort Study of Arbovirus and Other Emerging Virus Infections in Fiji: AEVI-Fiji Cohort.
Spatial Repellents for Aedes-borne Virus Control in Sri Lanka
The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return Travelers
Virological and Immunological Determinants of Arbovirus Infection in New Caledonia
Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia
Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating
World Mosquito Program Noumea - Human Sample Component
Human Epidemiology of Newly Identified Arboviruses
Spatial Repellents for Arbovirus Control
Sero-epidemiology of Priority Arboviruses in French Guiana
Pilot Survey of Dengue Fever in Solomon Islands
Field Evaluation of Plant-based Mosquito Control